Abstract
Orthostatic intolerance results from maladaptation of circulatory system to the effects of gravitational force in upright position. Two main forms of orthostatic intolerance with distinct haemodynamic changes are orthostatic hypotension (OH) and postural orthostatic tachycardia syndrome (POTS). Orthostatic hypotension has three main variants defined by their temporal relationship to the act of standing: initial (10–30 s after standing), classical (1–3 min after standing) and delayed OH (beyond 3 min of standing), the two latter are characterized by persistent blood pressure (BP) fall. In POTS there is no BP fall on standing but excessive and continuous orthostatic tachycardia, usually accompanied by a spectrum of unspecific symptoms such as dizziness, discomfort, nausea, chest pain and palpitation. Symptoms of OH and POTS may be debilitating and occasionally manifest as syncope and fall injuries, the latter often observed in older individuals. The prevalence of OH increases with age, ranging from less than 5% below 40 years to more than 20% above 70 years, and with comorbidities, such as hypertension, diabetes, Parkinson’s disease, and kidney failure. Presence of OH heralds higher mortality and increased incidence of cardiovascular disease, with majority of patients being asymptomatic in normal conditions. In contrast, POTS affects predominantly young women (70–80%) within a range of 15–40 years and is usually accompanied by deconditioning and cognitive impairment. Management of orthostatic intolerance includes both non-pharmacological and pharmacological methods with limited efficacy in severe cases. Empirical treatment with vasoactive, volume-expanding and heart rate controlling drugs for POTS is widely used but rarely fully effective.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Smith JJ, Porth CM, Erickson M. Hemodynamic response to the upright posture. J Clin Pharmaco. 1994;34:375–86.
Fedorowski A, Melander O. Syndromes of orthostatic intolerance: a hidden danger. J Intern Med. 2013;273:322–35.
Shen WK, Sheldon RS, Benditt DG, Cohen MI, Forman DE, Goldberger ZD, Grubb BP, Hamdan MH, Krahn AD, Link MS, Olshansky B, Raj SR, Sandhu RK, Sorajja D, Sun BC, Yancy CW. 2017 ACC/AHA/HRS Guideline for the evaluation and management of patients with syncope: executive summary: a report of the American college of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2017;70:620–63.
Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A, Fedorowski A, Furlan R, Kenny RA, Martin A, Probst V, Reed MJ, Rice CP, Sutton R, Ungar A, van Dijk JG, Group ESCSD. 2018 ESC guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39:1883–948.
Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, Cheshire WP, Chelimsky T, Cortelli P, Gibbons CH, Goldstein DS, Hainsworth R, Hilz MJ, Jacob G, Kaufmann H, Jordan J, Lipsitz LA, Levine BD, Low PA, Mathias C, Raj SR, Robertson D, Sandroni P, Schatz I, Schondorff R, Stewart JM, Van Dijk JG. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21:69–72.
Fedorowski A. Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management. J Intern Med. 2019;285:352–66.
Sheldon RS, Grubb BP 2nd, Olshansky B, Shen WK, Calkins H, Brignole M, Raj SR, Krahn AD, Morillo CA, Stewart JM, Sutton R, Sandroni P, Friday KJ, Hachul DT, Cohen MI, Lau DH, Mayuga KA, Moak JP, Sandhu RK, Kanjwal K. 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015;12:e41–63.
Ricci F, De Caterina R, Fedorowski A. Orthostatic hypotension: epidemiology, prognosis, and treatment. J Am Coll Cardiol. 2015;66:848–60.
Shen WK, Sheldon RS, Benditt DG, Cohen MI, Forman DE, Goldberger ZD, Grubb BP, Hamdan MH, Krahn AD, Link MS, Olshansky B, Raj SR, Sandhu RK, Sorajja D, Sun BC, Yancy CW. 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: a report of the American college of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2017;70:e39–e110.
Sutton R. Clinical classification of syncope. Prog Cardiovasc Dis. 2013;55:339–44.
Jones PK, Gibbons CH. The role of autonomic testing in syncope. Auton Neurosci. 2014;184:40–5.
Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A, Fedorowski A, Furlan R, Kenny RA, Martin A, Probst V, Reed MJ, Rice CP, Sutton R, Ungar A, Van Dijk JG, Group ESCSD. Practical instructions for the 2018 ESC guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39:e43–80.
Goodman BP. Evaluation of postural tachycardia syndrome (POTS). Auton Neurosci. 2018;215:12–9.
Isaacson S, Shill HA, Vernino S, Ziemann A, Rowse GJ. Safety and durability of effect with long-term, open-label droxidopa treatment in patients with symptomatic neurogenic orthostatic hypotension (NOH303). J Parkinsons Dis. 2016;6:751–9.
Garland EM, Celedonio JE, Raj SR. Postural Tachycardia syndrome: beyond orthostatic intolerance. Curr Neurol Neurosci Rep. 2015;15:60.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Fedorowski, A. (2020). Orthostatic Hypotension Variants, POTS, and Less Well-Defined Autonomic Dysfunction. In: Brignole, M., Benditt, D. (eds) Syncope. Springer, Cham. https://doi.org/10.1007/978-3-030-44507-2_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-44507-2_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-44506-5
Online ISBN: 978-3-030-44507-2
eBook Packages: MedicineMedicine (R0)